NCT04216927View on ClinicalTrials.gov

NO During CPB in Neonates to Reduce Risk of AKI

PHASE3RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 10, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
AKICHD - Congenital Heart DiseaseSurgery
Interventions
DRUG

Nitric Oxide

gNO will be entrained at 20 ppm into the oxygenator of the CPB circuit

DRUG

Oxygen

Oxygen alone will be entrained for placebo arm

Trial Locations (1)

45229

RECRUITING

Cincinnati Children's Hospital Medical Center, Cincinnati

Sponsors

Collaborators (1)

Mallinckrodt
All Listed Sponsors
collaborator

Mallinckrodt

INDUSTRY

collaborator

Indiana University

OTHER

lead

Children's Hospital Medical Center, Cincinnati

OTHER